Grow Opportunity

Topic
Psilocybin

Advertisement

Stories continue below

PsilocybinNewsBusinessTesting

December 20, 2023
Mydecine Innovations Group receives notice of allowance from USPTO for its MYCO 005 compound

PsilocybinFeaturesOpinionPsychedelics

December 18, 2023
Canada owes its veterans new mental health tools: Access to psychedelic therapies is overdue

PsilocybinNewsInternationalProduction

December 12, 2023
Rose Hill and ACS Laboratory join forces to pioneer psilocybin testing standards

PsilocybinNewsLegal

December 11, 2023
Psilocybin will be legalized in a court case

PsilocybinNewsBusinessPsychedelics

November 27, 2023
Lophos Pharmaceuticals Corp. Receives Health Canada approval for expanded controlled substance operations

PsilocybinFeaturesBusinessLegal

November 20, 2023
Raids on magic mushroom dispensaries are a knee-jerk reaction, but taking a blind-eye approach only allows the market to run wild

PsilocybinNewsInternationalRegulations

October 10, 2023
California Gov. Gavin Newsom vetoes bill that would have decriminalized psychedelic mushrooms

PsilocybinNewsRegulations

October 3, 2023
Federal Court ruling sets back health workers seeking psilocybin mushroom access

PsilocybinNewsBusinessInternational

August 3, 2023
World’s first legal exporter of psilocybin launches ONE Psychedelic Retreats and PATOO psilocybin gummy

PsilocybinNewsLegalPsychedelics

July 17, 2023
Experts doubt whether illegal magic mushroom stores will advance drug policy

PsilocybinNewsCultivationProduction

February 23, 2023
HYTN Innovations cultivates psilocybin mushrooms and upgrades equipment for API development

PsilocybinNewsBusinessInternationalProduction

January 25, 2023
Psyence and Eden Labs extraction and product development collaboration

PsilocybinFeaturesLegalMedicalRegulations

January 23, 2023
Barriers to access: Plant medicine as constitutional right, part two

PsilocybinFeaturesMedicalOpinionRegulationsResearch

January 17, 2023
Barriers to access: Plant medicine as constitutional right, part one

PsilocybinNewsEventsInternationalResearch

November 24, 2022
reMind Psychedelics Business Forum brings together leading industry experts for inaugural MJBizCon event

PsilocybinNewsResearchWellness

October 18, 2022
LOVE Pharma’s update on launch of sponsored psilocybin trials at John Hopkins University

PsilocybinNewsCultivationLegalTesting

October 17, 2022
HYTN awarded controlled drugs and substances dealer’s license allowing for production and sale of psilocybin